Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
Whenever a story on fatty liver disease appears in the media, Columbia hepatologist Julia Wattacheril does what most people try to avoid: she reads ...